Meanwhile, DTX Exchange is defying this trend with thousands of traders flocking in and securing over $13.5 million in its viral presale. As Solana's price is struggling along with declining trading ...

An FDA-approved digital therapeutic (DTx) that can be used to help people living with major depressive disorder (MDD) has been launched in the US and is available in mobile app stores. Otsuka ...

DTX Exchange is taking the crypto world by storm in 2025. This AI-driven platform aims to provide access to over 120,000 assets, including stocks, forex, commodities, ETFs, and cryptocurrencies. With ...

Meanwhile, Binance Coin (BNB) continues to decline in the volatile market. Among the latest entrants, investors witnessed an uprising of DTX Exchange as this new platform shows promise to transform ...

However, a new competitor called DTX Exchange emerged with a hybrid trading system after seeing the DTX token raise over $13.4M in presale funding. Many analysts predict that the DTX Exchange token ...

Crypto market investors are on the lookout for the next winners in 2025. Many crypto coins seem to be doing well, but DTX Exchange (DTX), Ethereum (ETH), and Cardano (ADA) seem poised for great ...

The XRP price, while peaking at $3.40 in January, crashed and now trades at $2.40. Despite this, a new player, DTX Exchange, stole the spotlight with its presale momentum, raising over $13.5 million.

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...